Friedman David Matthew

Benitec Biopharma Inc. · Director

Friedman David Matthew is listed in public filings as director. This Friedman David Matthew insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Benitec Biopharma Inc. (BNTC). Investors use Friedman David Matthew's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Benitec Biopharma Inc.BNTC$401k35k sharesGrant / ExerciseMay 26, 2026$400.8K35k shares$11.45--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Historical actions before the latest disclosure date will appear here after more snapshots are available.